Remission of nephrotic syndrome due to AA-amyloidosis, complicating familiar Mediterranean fever, with tocilizumab

Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S169. Epub 2015 Jan 9.

Authors

John Serelis¹, Sophia Christaki¹, Fotini N Skopouli²

Affiliations

¹ Department of Internal Medicine and Clinical Immunology, Euroclinic Hospital, Athens, Greece.
² Department of Internal Medicine and Clinical Immunology, Euroclinic Hospital, Athens, Greece. fskopouli@euroclinic.gr.

PMID: 25572486

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Amyloidosis / blood
Amyloidosis / diagnosis
Amyloidosis / drug therapy*
Amyloidosis / etiology
Antibodies, Monoclonal, Humanized / therapeutic use*
Biomarkers / blood
Familial Mediterranean Fever / complications
Familial Mediterranean Fever / diagnosis
Familial Mediterranean Fever / drug therapy*
Female
Humans
Immunosuppressive Agents / therapeutic use*
Nephrotic Syndrome / diagnosis
Nephrotic Syndrome / drug therapy*
Nephrotic Syndrome / etiology
Pregnancy
Remission Induction
Serum Amyloid A Protein / metabolism*
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
Biomarkers
Immunosuppressive Agents
Serum Amyloid A Protein
tocilizumab